← Study Library
In vitro · 2016 · n=50
Preclinicalcounts toward this tierThe TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis
Liu Q, Hu X, Zhang X, Dai L, Duan X, Zhou C, Ao Y · Molecular Therapy
Preclinicalcounts toward this tier
The thymosin β4 pseudogene transcript lncRNA-MSR was upregulated in damaged human OA cartilage and activated by mechanical strain, and it raised TMSB4 expression by sponging miR-152; blocking it protected against degradation, so the authors propose the Tβ4 axis as a therapeutic target to inhibit, not to supply.
- Population
- Damaged and intact cartilage from 50 patients; human chondrocytes under cyclic tensile strain
- Intervention
- None — expression profiling, plus lncRNA manipulation in chondrocytes
- Comparator
- Intact cartilage from the same joints
- Limitations
- Expression and cell-culture work; the therapeutic inference (inhibit the axis) has not been tested in a joint in vivo.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental · key study